It turns out that insulin doesn’t magically freeze if you put it in your checked plane luggage! #ADC2024 #betterposter #myfirstposter

Very concerning when a top-level domain registry disables your domain a month after accepting renewal payment, and then does not respond to any support tickets or accept phone calls. Anyone else having trouble with @COCCA_Council ? (not bionicwookiee, another domain).

I missed the screenshot, but there was a very unfortunate association of body-type image with T2D in Jorgen Rungby's talk about Neuroprotective mechanisms. I almost spat my drink over my screen. #dedoc #EASD2023.

RT @PracticalDeeb: @rama_lakshman1 compared ultra-rapid insulin (Lyumjev) to rapid insulin in @CamAPS_FX and found surperior results. #EAS….

RT @thediabeticsurv: The auto-syringe ! A must visit at #EASD2023 the stall of something truly unique #dedoc #payit….

A presentation comparing results from "1st-generation and 2nd-generation commercial AID systems". While I wasn't surprised to see 670G in the 1st-gen bracket, it was interesting to see CIQ as the "2nd-gen" example. I wonder how many "generations" are labelled! #EASD2023 #Dedoc.

Off-hand comment by Tim Heise that "of course cardiovascular outcomes are more of an issue for Type 2 [than Type 1]". This was in the Q&A after a talk about an experimental basal insulin. REALLY? I hope no-one's assuming CV outcomes are NOT important for T1! #dedoc #EASD2023.

900 years of lived experience! Yes mine are in there too. #dedoc #EASD2023.

If you're there, please do attend! It's important for EVERYONE in the sphere of diabetes. #dedoc #EASD2023.

Good to see the updated TIR recommendations for clinical trials presented. I'll have to update my CGM reports to include some of the new metrics. #ADA2023 #dedoc @dedocORG.

A real-world study of MDI (using Novo “connected” pens) quantifying the frequency and impact of missed insulin doses. #ADA2023 #dedoc @dedocORG

OS-AID found to be non-inferior to commercial AID in a Canadian observational T1 diabetes study! #ADA2023 #dedoc @dedocORG #WeAreNotWaiting

Good to see data being published about fasting with T1D during Ramadan (using a large dataset gathered in KSA). Conclusion of the paper is that automated insulin delivery systems are the safest and most effective solution. #ADA2023 #dedocvoices #dedoc.

Down to the top 3 in the ADA Innovation Challenge: the Go-Pen, NiCH, and Minutia. #ADA2023 #dedocvoices #dedoc.

Soon the 3 VC judges on stage get to vote on the 6 finalists, plus the audience gets to vote as well. We'll see soon who wins!.

Sixth (last) finalist in the ADA Innovation Challenge: Minutia's stem-cell-derived insulin-generating cells (small device in the forearm). The cells provide real-time data on their viability/etc and apparently don't need immunotherapy. #ADA2023 #dedocvoices #dedoc.

7-day reservoir (single-use enforced by hardware) and the pen has a 3-year design life.

Has a reservoir/cartridge which is filled on-site from vials/etc, so doesn't depend on particular containers. #ADA2023 #dedoc.

Fifth finalist in the ADA Innovation Challenge: the Go-Pen. An affordable insulin pen for the developing world. Simple technology, with the potential for massive health impact by replacing syringes. #ADA2023 #dedocvoices #dedoc.